DE60140263D1 - Arylalkanen-sulfonamiden mit endothelin-antagonistischer aktivität - Google Patents

Arylalkanen-sulfonamiden mit endothelin-antagonistischer aktivität

Info

Publication number
DE60140263D1
DE60140263D1 DE60140263T DE60140263T DE60140263D1 DE 60140263 D1 DE60140263 D1 DE 60140263D1 DE 60140263 T DE60140263 T DE 60140263T DE 60140263 T DE60140263 T DE 60140263T DE 60140263 D1 DE60140263 D1 DE 60140263D1
Authority
DE
Germany
Prior art keywords
arylalkanenesulfonamides
antagonistic activity
endothelin antagonistic
endothelin
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140263T
Other languages
English (en)
Inventor
Thomas Weller
Martin Bolli
Christoph Boss
Martine Clozel
Walter Fischli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actelion Pharmaceuticals Ltd
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Application granted granted Critical
Publication of DE60140263D1 publication Critical patent/DE60140263D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60140263T 2000-09-25 2001-08-28 Arylalkanen-sulfonamiden mit endothelin-antagonistischer aktivität Expired - Lifetime DE60140263D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0009327 2000-09-25
PCT/EP2001/009894 WO2002024665A1 (en) 2000-09-25 2001-08-28 Arylalkane-sulfonamides having endothelin-antagonist activity

Publications (1)

Publication Number Publication Date
DE60140263D1 true DE60140263D1 (de) 2009-12-03

Family

ID=8164105

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140263T Expired - Lifetime DE60140263D1 (de) 2000-09-25 2001-08-28 Arylalkanen-sulfonamiden mit endothelin-antagonistischer aktivität

Country Status (18)

Country Link
US (1) US7091201B2 (de)
JP (1) JP2004509874A (de)
KR (1) KR100835770B1 (de)
CN (1) CN1326841C (de)
AR (1) AR032896A1 (de)
AT (1) ATE446289T1 (de)
AU (2) AU2002212171B2 (de)
BR (1) BR0114082A (de)
CA (1) CA2423351C (de)
DE (1) DE60140263D1 (de)
ES (1) ES2333409T3 (de)
HU (1) HUP0303364A3 (de)
IL (1) IL154364A0 (de)
MX (1) MXPA03001991A (de)
NO (1) NO20031332L (de)
NZ (1) NZ524172A (de)
WO (1) WO2002024665A1 (de)
ZA (1) ZA200302292B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0217431D0 (en) 2002-07-27 2002-09-04 Astrazeneca Ab Novel compounds
ES2295685T3 (es) 2002-08-24 2008-04-16 Astrazeneca Ab Derivados de pirimidina como moduladores de la actividad del receptor de quimioquinas.
SE0301653D0 (sv) * 2003-06-05 2003-06-05 Astrazeneca Ab Novel compounds
SE0301654D0 (sv) * 2003-06-05 2003-06-05 Astrazeneca Ab Novel compounds
CN1930135B (zh) 2004-03-05 2011-12-28 弗·哈夫曼-拉罗切有限公司 作为p2x3和p2x2/3拮抗剂的二氨基嘧啶
MX2007002240A (es) 2004-08-28 2007-04-20 Astrazeneca Ab Derivados de pirimidinosulfonamida como moduladores del receptor quimiocina.
BRPI0615613A2 (pt) 2005-09-01 2009-05-19 Hoffmann La Roche diaminopirimidinas como moduladores de p2x3 e p3x2/3
JP4850913B2 (ja) 2005-09-01 2012-01-11 エフ．ホフマン−ラ ロシュ アーゲー Ｐ２ｘ３及びｐ２ｘ２／３調節因子としてのジアミノピリジン
JP4850911B2 (ja) 2005-09-01 2012-01-11 エフ．ホフマン−ラ ロシュ アーゲー Ｐ２ｘ３およびｐ２ｘ２／３モジュレーターとしてのジアミノピリミジン
US9181231B2 (en) * 2011-05-03 2015-11-10 Agios Pharmaceuticals, Inc Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
CN103864701B (zh) * 2014-03-10 2016-08-24 常熟市金申医化制品有限责任公司 4-磺胺-5-甲氧基-6-氯嘧啶的制备方法
EA202191104A1 (ru) 2018-10-23 2021-07-19 Степ Фарма С.А.С. Производные аминопиридина/пиразина в качестве ингибиторов ctps1
WO2020245664A1 (en) * 2019-06-04 2020-12-10 Step Pharma S.A.S. N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2h-pyran-4-carboxamide derivatives and related compounds as human ctps1 inhibitors for the treatment of proliferative diseases
US20230086703A1 (en) * 2019-06-04 2023-03-23 Step Pharma S.A.S. N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1549494A (de) 1967-10-31 1968-12-13
TW394761B (en) 1993-06-28 2000-06-21 Hoffmann La Roche Novel Sulfonylamino Pyrimidines
JP2790065B2 (ja) * 1993-12-17 1998-08-27 田辺製薬株式会社 ベンゼンスルホンアミド誘導体及びその製法
US5837708A (en) * 1994-11-25 1998-11-17 Hoffmann-La Roche Inc. Sulphonamides
JP3013752B2 (ja) * 1995-05-16 2000-02-28 田辺製薬株式会社 スルホンアミド誘導体
US5739333A (en) 1995-05-16 1998-04-14 Tanabe Seiyaku Co., Ltd. Sulfonamide derivative and process for preparing the same
JP3067131B2 (ja) * 1995-06-16 2000-07-17 田辺製薬株式会社 医薬組成物
RU2172735C2 (ru) * 1995-12-20 2001-08-27 Яманоути Фармасьютикал Ко., Лтд. Арилэтенсульфонамидные производные и фармацевтическая композиция
JP3116347B2 (ja) * 1996-11-13 2000-12-11 田辺製薬株式会社 医薬組成物
AU8035698A (en) * 1997-06-19 1999-01-04 Yamanouchi Pharmaceutical Co., Ltd. Substituted lower alkanesulfonamide derivatives and pharmaceutical composition containing the same
JPH11343239A (ja) * 1998-03-31 1999-12-14 Tanabe Seiyaku Co Ltd 排尿障害の予防・治療剤

Also Published As

Publication number Publication date
US20040102464A1 (en) 2004-05-27
AU2002212171B2 (en) 2006-12-14
ZA200302292B (en) 2004-06-30
NO20031332D0 (no) 2003-03-24
WO2002024665A8 (en) 2002-06-06
US7091201B2 (en) 2006-08-15
MXPA03001991A (es) 2003-06-24
KR20030029979A (ko) 2003-04-16
WO2002024665A1 (en) 2002-03-28
HUP0303364A3 (en) 2004-04-28
NO20031332L (no) 2003-03-24
AR032896A1 (es) 2003-12-03
BR0114082A (pt) 2003-07-22
CA2423351A1 (en) 2002-03-28
ATE446289T1 (de) 2009-11-15
IL154364A0 (en) 2003-09-17
KR100835770B1 (ko) 2008-06-09
HUP0303364A2 (hu) 2004-03-01
AU1217102A (en) 2002-04-02
CN1326841C (zh) 2007-07-18
JP2004509874A (ja) 2004-04-02
CA2423351C (en) 2010-12-21
CN1633418A (zh) 2005-06-29
NZ524172A (en) 2004-09-24
ES2333409T3 (es) 2010-02-22

Similar Documents

Publication Publication Date Title
BR0105361B1 (pt) artigo absorvente.
BR0100865B8 (pt) artigo absorvente.
BR0103836B1 (pt) artigo absorvente.
PT1341791E (pt) Imidazoquinolinas substituidas com tioeter
BR0100151B1 (pt) artigo absorvente.
BR0214972B1 (pt) artigo absorvente.
PT1199054E (pt) Utensilio de liquefractura
BR0103754B1 (pt) artigo descartÁvel.
NO20030795D0 (no) Kinazolinderivater
DE10196503T1 (de) Steckverschlüsse mit winkeligen Vorsprüngen
DE60126705D1 (de) Rafflamellenstore mit variabler Neigung
DE60140838D1 (de) Saugfähiger Gegenstand
BR0100961B1 (pt) artigo absorvente.
DE60140263D1 (de) Arylalkanen-sulfonamiden mit endothelin-antagonistischer aktivität
BR0102028B1 (pt) artigo absorvente.
NO20032291D0 (no) Pyrimidinderivater
DE60143148D1 (de) En mit honigwaben
BR0100962B1 (pt) artigo absorvente.
DE50113112D1 (de) Schaltungsanordnung
BR0107047B1 (pt) artigo absorvente.
BR0212092B1 (pt) artigo absorvente.
ATE476164T1 (de) Saugfähiger artikel
DK1180326T3 (da) o-Phenylphenolat-koncentrater
ATA21332000A (de) Möbel
DK1195114T3 (da) Møbelglider

Legal Events

Date Code Title Description
8364 No opposition during term of opposition